ArticleMolecular therapy. Methods & clinical development2018

Determining the Minimally Effective Dose of a Clinical Candidate AAV Vector in a Mouse Model of Crigler-Najjar Syndrome.

Jenny A Greig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.